Resulting tumor-bearing mice were then randomized into the four arms, namely vehicle, docetaxel (20mg/kg), Stat3 inhibitor (C188) (12.5 mg/kg), and the inhibitor+docetaxel combination. This evidence concerns the gene STAT3 and neoplasm.